Company intelligence / Profile preview

ProBiora Health

Tampa, Florida, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

ProBiora Health's products, based on the patented ProBiora3® probiotic blend, have been evaluated in academic and peer-reviewed studies showing efficacy in inhibiting oral pathogens and supporting gum and tooth health; the products are marketed directly to consumers and dental professionals for oral care in both humans and animals[1][4][5][9].

Therapeutic areas: Infectious DiseasesGastroenterologyOtherHematology
Modalities: Live biotherapeutic product therapyMicrobial therapy (oral probiotic blends)
Industry: Non-Drug Biotech

Partnerships

Distributed in dental offices and through e-commerce; no major pharma/biotech partnerships disclosed

Beyond the preview

Go deeper on ProBiora Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProBiora Health.

Explore the full profile